Caricamento...
The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
BACKGROUND: Acquired haemophilia A (AHA) is a rare bleeding disorder caused by the development of specific autoantibodies against naturally occurring factor VIII (FVIII). Although about half of cases are idiopathic, AHA may be associated with several non-neoplastic conditions, autoimmune disorders,...
Salvato in:
| Pubblicato in: | Blood Transfus |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Edizioni SIMTI - SIMTI Servizi Srl
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918557/ https://ncbi.nlm.nih.gov/pubmed/26509821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2015.0090-15 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|